National Vaccine Advisory Committee, 62296-62297 [E8-24893]
Download as PDF
62296
Federal Register / Vol. 73, No. 203 / Monday, October 20, 2008 / Notices
Trans No.
Acquiring
Acquired
Entities
Transactions Granted Early Termination—06/27/2008
20081257 ...........
Comtech Telecommunications Corp. .....
FOR FURTHER INFORMATION CONTACT:
Sandra M. Peay, Contact Representative,
or Renee Hallman, Contact
Representative, Federal Trade
Commission, Premerger Notification
Office, Bureau of Competition, Room H–
303, Washington, DC 20580, (202) 326–
3100.
By Direction of the Commission.
Donald S. Clark,
Secretary.
[FR Doc. E8–24649 Filed 10–17–08; 8:45 am]
BILLING CODE 6750–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Vaccine Advisory Committee
Department of Health and
Human Services, Office of the Secretary,
Office of Public Health and Science.
ACTION: Notice.
AGENCY:
mstockstill on PROD1PC66 with NOTICES
Authority: 42 U.S.C. 300aa–5, Section 2105
of the Public Health Service (PHS) Act, as
amended. The Committee is governed by the
provisions of Public Law 92–463, as
amended (5 U.S.C. Appendix 2), which sets
forth standards for the formation and use of
advisory committees.
SUMMARY: The National Vaccine
Program Office (NVPO), a program
office within the Office of Public Health
and Science, DHHS, is soliciting
nominations of qualified candidates to
be considered for appointment as
members to the National Vaccine
Advisory Committee (NVAC). The
activities of this Committee are
governed by the Federal Advisory
Committee Act (FACA).
Consistent with the National Vaccine
Plan, the Committee advises and makes
recommendations to the Assistant
Secretary for Health in his capacity as
the Director of the National Vaccine
Program, on matters related to the
Program’s responsibilities. Specifically,
the Committee studies and recommends
ways to encourage the availability of an
adequate supply of safe and effective
vaccination products in the United
States, and recommends research
priorities and other measures to
enhance the safety and efficacy of
vaccines. The Committee also advises
the Assistant Secretary for Health in the
implementation of Sections 2102 and
2103 of the PHS Act; and identifies
VerDate Aug<31>2005
16:42 Oct 17, 2008
Jkt 217001
Radyne Corporation ...............................
annually the most important areas of
government and non-government
cooperation that should be considered
in implementing Sections 2102 and
2103 of the PHS Act.
DATES: Nominations for membership on
the Committee must be received no later
than 5 p.m. EDT on November 21, 2008,
at the address below.
ADDRESSES: All nominations should be
mailed or delivered to: Bruce G. Gellin,
MD, MPH, Executive Secretary, NVAC,
Office of Public Health and Science,
Department of Health and Human
Services, 200 Independence Avenue,
SW., Room 443–H, Hubert H. Humphrey
Building, Washington, DC 20201.
FOR FURTHER INFORMATION CONTACT: Ms.
Andrea Krull, Public Health Advisor,
National Vaccine Program Office,
Department of Health and Human
Services, 200 Independence Avenue,
SW., Room 443–H, Hubert H. Humphrey
Building, Washington, DC 20201; (202)
690–5566; nvpo@hhs.gov.
A copy of the Committee charter
which includes the Committee’s
structure and functions as well as a list
of the current membership can be
obtained by contacting Ms. Krull or by
accessing the NVAC Web site at:
www.hhs.gov/nvpo/nvac.
SUPPLEMENTARY INFORMATION:
Committee Function, Qualifications,
and Information Required: As part of an
ongoing effort to enhance deliberations
and discussions with the public on
vaccine and immunization policy,
nominations are being sought for
interested individuals to serve on the
Committee. Individuals selected for
appointment to the Committee will
serve as voting members. Public
members shall be selected from
individuals who are engaged in vaccine
research or the manufacture of vaccines,
or who are physicians, members of
parent organizations concerned with
immunizations, representatives of state
or local health agencies or public health
organizations. Representative members
shall be selected from the vaccine
manufacturing industry who are
engaged in vaccine research or the
manufacture of vaccines. Anticipated
vacancies include both public and
representative member positions.
Individuals selected for appointment to
the Committee can be invited to serve
terms of up to four years.
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
Radyne Corporation.
Nominations should be typewritten.
The following information should be
included in the package of material
submitted for each individual being
nominated for consideration: (1) A letter
of nomination that clearly states the
name and affiliation of the nominee, the
basis for the nomination (i.e. , specific
attributes which qualify the nominee for
service in this capacity), and a statement
that the nominee is willing to serve as
a member of the Committee; (2) the
nominator’s name, address and daytime
telephone number, and the home and/
or work address, telephone number, and
e-mail address of the individual being
nominated; and (3) a current copy of the
nominee’s curriculum vitae.
Applications cannot be submitted by
facsimile. The names of Federal
employees should not be nominated for
consideration of appointment to this
Committee.
The Department makes every effort to
ensure that the membership of HHS
Federal advisory committees is fairly
balanced in terms of points of view
represented and the committee’s
function. Every effort is made that a
broad representation of geographic
areas, gender, ethnic and minority
groups, and the disabled are given
consideration for membership on HHS
Federal advisory committees.
Appointment to this committee shall be
made without discrimination on the
basis of age, race, ethnicity, gender,
sexual orientation, disability, and
cultural, religious, or socioeconomic
status.
The Standards of Ethical Conduct for
Employees of the Executive Branch are
applicable to individuals who are
appointed as public members of Federal
advisory committees. Individuals
appointed to serve as public members of
Federal advisory committees are
classified as special Government
employees (SGEs). SGEs are
Government employees for purposes of
the conflict of interest laws. Therefore,
individuals appointed to serve as public
members of NVAC are subject to an
ethics review. The ethics review is
conducted to determine if the
individual has any interests and/or
activities in the private sector that may
conflict with performance of their
official duties as a member of the
Committee. Individuals appointed to
serve as public members of the
E:\FR\FM\20OCN1.SGM
20OCN1
Federal Register / Vol. 73, No. 203 / Monday, October 20, 2008 / Notices
Committee will be required to disclose
information regarding financial
holdings, consultancies, and research
grants and/or contracts.
Dated: October 6, 2008.
Bruce Gellin,
Director, National Vaccine Program Office,
Executive Secretary, National Vaccine
Advisory Committee.
[FR Doc. E8–24893 Filed 10–17–08; 8:45 am]
BILLING CODE 4150–44–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the National Biodefense
Science Board
Department of Health and
Human Services, Office of the Secretary.
ACTION: Notice.
mstockstill on PROD1PC66 with NOTICES
AGENCY:
SUMMARY: As stipulated by the Federal
Advisory Committee Act, the U.S.
Department of Health and Human
Services is hereby giving notice that the
National Biodefense Science Board
(NBSB) will be holding a public
meeting. The meeting is open to the
public.
DATES: The NBSB will hold a public
meeting on November 18, 2008 from
8:30 a.m. to 5 p.m. EST and on
November 19, 2008 from 8:30 a.m. to
12:30 p.m.
ADDRESSES: The Sheraton National
Hotel, 900 S. Orme Street, Arlington,
VA 22204.
Phone: 703–521–1900.
FOR FURTHER INFORMATION CONTACT:
CAPT Leigh A. Sawyer, D.V.M., M.P.H.,
Executive Director, National Biodefense
Science Board, Office of the Assistant
Secretary for Preparedness and
Response, U.S. Department of Health
and Human Services, 200 Independence
Ave., SW., Room 638G, Washington, DC
20201; 202–205–3815; fax: 202–205–
0613; e-mail address:
leigh.sawyer@hhs.gov.
SUPPLEMENTARY INFORMATION: Pursuant
to section 319M of the Public Health
Service Act (42 U.S.C. 247d–7f) and
section 222 of the Public Health Service
Act (42 U.S.C. 217a), the Department of
Health and Human Services established
the National Biodefense Science Board.
The Board shall provide expert advice
and guidance to the Secretary on
scientific, technical, and other matters
of special interest to the Department of
Health and Human Services regarding
current and future chemical, biological,
nuclear, and radiological agents,
whether naturally occurring, accidental,
or deliberate. The Board may also
provide advice and guidance to the
VerDate Aug<31>2005
16:42 Oct 17, 2008
Jkt 217001
62297
Secretary on other matters related to
public health emergency preparedness
and response.
The NBSB will consider
recommendations prepared by the
Disaster Mental Health Subcommittee.
The Subcommittee was established by
the NBSB to help fulfill the requirement
of HSPD–21, paragraph 31, which
directs the Secretary, U.S. Department
of Health and Human Services, to
convene a committee of subject matter
experts and, to submit to the Secretary
of Health and Human Services
recommendations for protecting,
preserving, and restoring individual and
community mental health in
catastrophic health event settings,
including pre-event, intra-event, and
post-event education, messaging, and
interventions.
Additional topics will be considered
during the public meeting. A tentative
schedule will be made available on
November 1, 2008 at the NBSB Web site,
https://www.hhs.gov/aspr/omsph/nbsb.
This agenda is subject to change as
priorities dictate.
Any member of the public interested
in presenting oral comments at the
meeting may notify the Contact person
listed on this notice by November 10,
2008. Interested individuals and
representatives of an organization may
submit a letter of intent and a brief
description of the organization
represented. In addition, any interested
person may file written comments with
the committee. All written comments
must be received prior to November 10,
2008 and should be sent by e-mail with
‘‘NBSB Public Comment’’ as the subject
line or by regular mail to the Contact
person listed above. Individuals who
plan to attend and need special
assistance, such as sign language
interpretation or other reasonable
accommodations, should notify the
designated contact person.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
August 8, 2008.
William C. Vanderwagen,
Assistant Secretary for Preparedness and
Response, U.S. Department of Health and
Human Services.
[FR Doc. E8–24843 Filed 10–17–08; 8:45 am]
SUPPLEMENTARY INFORMATION:
BILLING CODE 4150–37–P
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
Administration for Children and
Families
President’s Committee for People With
Intellectual Disabilities; Notice of
Meeting
President’s Committee for
People with Intellectual Disabilities
(PCPID).
ACTION: Notice of Quarterly Meeting.
AGENCY:
November 19, 2008, from 8:30
a.m. to 5 p.m. EST; and November 20,
2008, from 8 a.m. to 9.a.m. The meeting
will be open to the public.
ADDRESSES: The meeting will be held in
Room 705A of the Hubert H. Humphrey
Building, 200 Independence Ave., SW.,
Washington, DC 20201. Individuals who
would like to participate via conference
call may do so by dialing 888–603–
6970, passcode: PCPID. Individuals who
will need accommodations for a
disability in order to attend the meeting
(e.g., sign language interpreting services,
assistive listening devices, materials in
alternative formats such as large print or
Braille) should notify MJ Karimi via email at
Madjid.KarimieAsl@ACF.hhs.gov, or via
telephone at 202–619–0634, no later
than November 12, 2008. PCPID will
attempt to meet requests made after that
date, but cannot guarantee availability.
All meeting sites are barrier free.
Agenda: PCPID will meet to continue
work on the 2009 Annual Report to the
President.
Additional Information: For further
information, please contact Sally D.
Atwater, Executive Director, President’s
Committee for People with Intellectual
Disabilities, The Aerospace Center,
Second Floor West, 370 L’Enfant
Promenade, SW., Washington, DC
20447. Telephone: 202–619–0634. Fax:
202–205–9591. E-mail:
satwater@acf.hhs.gov.
DATES:
PCPID
acts in an advisory capacity to the
President and the Secretary of Health
and Human Services on a broad range
of topics relating to programs, services
and supports for persons with
intellectual disabilities. PCPID, by
Executive Order, is responsible for
evaluating the adequacy of current
practices in programs, services and
supports for persons with intellectual
disabilities, and for reviewing legislative
proposals that impact the quality of life
experienced by citizens with
intellectual disabilities and their
families.
E:\FR\FM\20OCN1.SGM
20OCN1
Agencies
[Federal Register Volume 73, Number 203 (Monday, October 20, 2008)]
[Notices]
[Pages 62296-62297]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-24893]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Vaccine Advisory Committee
AGENCY: Department of Health and Human Services, Office of the
Secretary, Office of Public Health and Science.
ACTION: Notice.
-----------------------------------------------------------------------
Authority: 42 U.S.C. 300aa-5, Section 2105 of the Public Health
Service (PHS) Act, as amended. The Committee is governed by the
provisions of Public Law 92-463, as amended (5 U.S.C. Appendix 2),
which sets forth standards for the formation and use of advisory
committees.
SUMMARY: The National Vaccine Program Office (NVPO), a program office
within the Office of Public Health and Science, DHHS, is soliciting
nominations of qualified candidates to be considered for appointment as
members to the National Vaccine Advisory Committee (NVAC). The
activities of this Committee are governed by the Federal Advisory
Committee Act (FACA).
Consistent with the National Vaccine Plan, the Committee advises
and makes recommendations to the Assistant Secretary for Health in his
capacity as the Director of the National Vaccine Program, on matters
related to the Program's responsibilities. Specifically, the Committee
studies and recommends ways to encourage the availability of an
adequate supply of safe and effective vaccination products in the
United States, and recommends research priorities and other measures to
enhance the safety and efficacy of vaccines. The Committee also advises
the Assistant Secretary for Health in the implementation of Sections
2102 and 2103 of the PHS Act; and identifies annually the most
important areas of government and non-government cooperation that
should be considered in implementing Sections 2102 and 2103 of the PHS
Act.
DATES: Nominations for membership on the Committee must be received no
later than 5 p.m. EDT on November 21, 2008, at the address below.
ADDRESSES: All nominations should be mailed or delivered to: Bruce G.
Gellin, MD, MPH, Executive Secretary, NVAC, Office of Public Health and
Science, Department of Health and Human Services, 200 Independence
Avenue, SW., Room 443-H, Hubert H. Humphrey Building, Washington, DC
20201.
FOR FURTHER INFORMATION CONTACT: Ms. Andrea Krull, Public Health
Advisor, National Vaccine Program Office, Department of Health and
Human Services, 200 Independence Avenue, SW., Room 443-H, Hubert H.
Humphrey Building, Washington, DC 20201; (202) 690-5566; nvpo@hhs.gov.
A copy of the Committee charter which includes the Committee's
structure and functions as well as a list of the current membership can
be obtained by contacting Ms. Krull or by accessing the NVAC Web site
at: www.hhs.gov/nvpo/nvac.
SUPPLEMENTARY INFORMATION:
Committee Function, Qualifications, and Information Required: As
part of an ongoing effort to enhance deliberations and discussions with
the public on vaccine and immunization policy, nominations are being
sought for interested individuals to serve on the Committee.
Individuals selected for appointment to the Committee will serve as
voting members. Public members shall be selected from individuals who
are engaged in vaccine research or the manufacture of vaccines, or who
are physicians, members of parent organizations concerned with
immunizations, representatives of state or local health agencies or
public health organizations. Representative members shall be selected
from the vaccine manufacturing industry who are engaged in vaccine
research or the manufacture of vaccines. Anticipated vacancies include
both public and representative member positions. Individuals selected
for appointment to the Committee can be invited to serve terms of up to
four years.
Nominations should be typewritten. The following information should
be included in the package of material submitted for each individual
being nominated for consideration: (1) A letter of nomination that
clearly states the name and affiliation of the nominee, the basis for
the nomination (i.e. , specific attributes which qualify the nominee
for service in this capacity), and a statement that the nominee is
willing to serve as a member of the Committee; (2) the nominator's
name, address and daytime telephone number, and the home and/or work
address, telephone number, and e-mail address of the individual being
nominated; and (3) a current copy of the nominee's curriculum vitae.
Applications cannot be submitted by facsimile. The names of Federal
employees should not be nominated for consideration of appointment to
this Committee.
The Department makes every effort to ensure that the membership of
HHS Federal advisory committees is fairly balanced in terms of points
of view represented and the committee's function. Every effort is made
that a broad representation of geographic areas, gender, ethnic and
minority groups, and the disabled are given consideration for
membership on HHS Federal advisory committees. Appointment to this
committee shall be made without discrimination on the basis of age,
race, ethnicity, gender, sexual orientation, disability, and cultural,
religious, or socioeconomic status.
The Standards of Ethical Conduct for Employees of the Executive
Branch are applicable to individuals who are appointed as public
members of Federal advisory committees. Individuals appointed to serve
as public members of Federal advisory committees are classified as
special Government employees (SGEs). SGEs are Government employees for
purposes of the conflict of interest laws. Therefore, individuals
appointed to serve as public members of NVAC are subject to an ethics
review. The ethics review is conducted to determine if the individual
has any interests and/or activities in the private sector that may
conflict with performance of their official duties as a member of the
Committee. Individuals appointed to serve as public members of the
[[Page 62297]]
Committee will be required to disclose information regarding financial
holdings, consultancies, and research grants and/or contracts.
Dated: October 6, 2008.
Bruce Gellin,
Director, National Vaccine Program Office, Executive Secretary,
National Vaccine Advisory Committee.
[FR Doc. E8-24893 Filed 10-17-08; 8:45 am]
BILLING CODE 4150-44-P